Novo’s obesity drug has serious warnings and barriers to overcome
World of DTC Marketing
JUNE 6, 2021
Wegovy also contains warnings for pancreatitis, gallbladder problems including gallstones, low blood sugar, acute kidney injury, eye retina damage, increased heart rate, and suicidal behavior or thinking. And, like any medication, there is a risk of side effects, some serious. appeared first on World of DTC Marketing.com.
Let's personalize your content